vs
Side-by-side financial comparison of LANDMARK BANCORP INC (LARK) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
LANDMARK BANCORP INC is the larger business by last-quarter revenue ($18.8M vs $13.2M, roughly 1.4× TriSalus Life Sciences, Inc.). LANDMARK BANCORP INC runs the higher net margin — 27.0% vs -73.9%, a 100.8% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 14.0%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 13.1%).
Landmark Bancorp Inc is a U.S.-based bank holding company operating Landmark National Bank, primarily serving communities across Kansas. It provides a full range of personal and commercial banking services including deposit accounts, residential mortgages, commercial loans, and wealth management solutions, catering to individual consumers, small businesses and local mid-sized enterprises.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
LARK vs TLSI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $18.8M | $13.2M |
| Net Profit | $5.1M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | — | -24.8% |
| Net Margin | 27.0% | -73.9% |
| Revenue YoY | 14.0% | 59.8% |
| Net Profit YoY | 7.8% | 3.5% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $18.8M | — | ||
| Q4 25 | $18.7M | $13.2M | ||
| Q3 25 | $18.2M | $11.6M | ||
| Q2 25 | $17.3M | $11.2M | ||
| Q1 25 | $16.5M | $9.2M | ||
| Q4 24 | $15.8M | $8.3M | ||
| Q3 24 | $15.9M | $7.3M | ||
| Q2 24 | $14.7M | $7.4M |
| Q1 26 | $5.1M | — | ||
| Q4 25 | $4.7M | $-9.8M | ||
| Q3 25 | $4.9M | $-10.8M | ||
| Q2 25 | $4.4M | $-8.3M | ||
| Q1 25 | $4.7M | $-10.4M | ||
| Q4 24 | $3.3M | $-10.1M | ||
| Q3 24 | $3.9M | $-2.4M | ||
| Q2 24 | $3.0M | $-4.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% |
| Q1 26 | — | — | ||
| Q4 25 | 31.7% | -24.8% | ||
| Q3 25 | 33.4% | -77.9% | ||
| Q2 25 | 30.9% | -65.4% | ||
| Q1 25 | 34.7% | -79.9% | ||
| Q4 24 | 15.2% | -91.8% | ||
| Q3 24 | 30.3% | -118.9% | ||
| Q2 24 | 24.5% | -111.0% |
| Q1 26 | 27.0% | — | ||
| Q4 25 | 32.1% | -73.9% | ||
| Q3 25 | 27.1% | -93.5% | ||
| Q2 25 | 25.4% | -73.9% | ||
| Q1 25 | 28.5% | -113.2% | ||
| Q4 24 | 26.5% | -122.4% | ||
| Q3 24 | 24.8% | -32.6% | ||
| Q2 24 | 20.5% | -58.8% |
| Q1 26 | — | — | ||
| Q4 25 | $0.66 | $-0.22 | ||
| Q3 25 | $0.85 | $-0.96 | ||
| Q2 25 | $0.75 | $-0.27 | ||
| Q1 25 | $0.81 | $-0.39 | ||
| Q4 24 | $0.47 | $-0.38 | ||
| Q3 24 | $0.68 | $-0.12 | ||
| Q2 24 | $0.52 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.9M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $-33.9M |
| Total Assets | $1.6B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $31.9M | — | ||
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $160.6M | $-33.9M | ||
| Q3 25 | $155.7M | $-26.7M | ||
| Q2 25 | $148.4M | $-19.4M | ||
| Q1 25 | $142.7M | $-34.4M | ||
| Q4 24 | $136.2M | $-25.9M | ||
| Q3 24 | $139.7M | $-20.4M | ||
| Q2 24 | $128.3M | $-25.3M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $35.3M | ||
| Q3 25 | $1.6B | $36.5M | ||
| Q2 25 | $1.6B | $41.3M | ||
| Q1 25 | $1.6B | $28.6M | ||
| Q4 24 | $1.6B | $24.0M | ||
| Q3 24 | $1.6B | $27.5M | ||
| Q2 24 | $1.6B | $32.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $21.6M | $-2.5M | ||
| Q3 25 | $10.3M | $-3.7M | ||
| Q2 25 | $439.0K | $-7.3M | ||
| Q1 25 | $8.0M | $-4.5M | ||
| Q4 24 | $14.2M | $-5.7M | ||
| Q3 24 | $8.1M | $-10.8M | ||
| Q2 24 | $4.4M | $-13.4M |
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $-2.5M | ||
| Q3 25 | $10.1M | $-3.9M | ||
| Q2 25 | $354.0K | $-7.4M | ||
| Q1 25 | $8.0M | $-5.3M | ||
| Q4 24 | $11.9M | $-5.8M | ||
| Q3 24 | $7.8M | $-11.0M | ||
| Q2 24 | $3.8M | $-13.5M |
| Q1 26 | — | — | ||
| Q4 25 | 112.5% | -19.1% | ||
| Q3 25 | 55.4% | -33.9% | ||
| Q2 25 | 2.0% | -66.1% | ||
| Q1 25 | 48.4% | -57.3% | ||
| Q4 24 | 75.6% | -69.7% | ||
| Q3 24 | 49.3% | -149.9% | ||
| Q2 24 | 25.6% | -183.1% |
| Q1 26 | — | — | ||
| Q4 25 | 3.2% | 0.3% | ||
| Q3 25 | 1.4% | 1.9% | ||
| Q2 25 | 0.5% | 0.8% | ||
| Q1 25 | 0.3% | 8.2% | ||
| Q4 24 | 14.7% | 0.6% | ||
| Q3 24 | 1.8% | 2.3% | ||
| Q2 24 | 4.2% | 0.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.56× | — | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | 0.10× | — | ||
| Q1 25 | 1.71× | — | ||
| Q4 24 | 4.34× | — | ||
| Q3 24 | 2.06× | — | ||
| Q2 24 | 1.45× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.